The firm is actively filing DePuy Pinnacle lawsuits on behalf of individuals who allegedly suffered metallosis, premature device failure and other serious complications related to the metal-on-metal hip implant.
(PRWEB) May 22, 2013
Pretrial proceedings for federal DePuy Pinnacle lawsuits are progressing. On May 15 a judge for the Pinnacle multidistrict litigation ordered Johnson & Johnson’s DePuy Orthopaedics unit to produce monitoring reports related to a federal investigation into the company’s medical device sales practices, according to court documents. The Rottenstein Law Group LLP, a DePuy Pinnacle law firm, maintains http://www.pinnaclelawsuit.com, which has more information on the metal-on-metal hip implant and how to file a lawsuit if appropriate.
Plaintiffs’ lawyers filed the motion to compel the release of the monitoring reports for use in the lawsuits pending in federal courts, according to court documents (In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Product Liability Litigation; MDL-2244, U.S. District Court for the Northern District of Texas). A 2007 agreement and the monitoring reports were the result of a U.S. Attorney’s office’s criminal investigation into allegations that DePuy offered kickbacks to surgeons to use its hip replacement products.
Read more: DePuy Pinnacle Lawsuit Update: Federal Court Orders DePuy to Produce Data from Sales Practices Investigation, Rottenstein Law Group LLP Reports
Hip replacement has remained one of the popular, most performed orthopedic procedures in the United Kingdom. The proof: Even the British member of Parliament and Defense Minister Andrew Robathan has undergone the same operation, media reports say. In a report from the BBC, Mr Robathan shares that he plans to file a lawsuit against DePuy Orthopaedics, a company under Johnson & Johnson, after experiencing severe pain.
Climbing the stairs and standing for long periods of time did not sit well for him because he would feel the pain on his hips. In the United Kingdom alone, about 100 men and women have had filed lawsuits against the manufacturer of their hip devices, as was reported in print and broadcast news reports.
The trials against one of Johnson & Johnson group of companies because of their DePuy ASR hip replacement system are gaining much attention, medical industry observers say. Plaintiffs of DePuy Pinnacle hip implants are even following the proceedings of the case because of the rumours of proposed settlements. There are over 7, 200 cases filed against DePuy Orthopaedics and the first two trials were only heard last month with the third one scheduled in May 2013. The Pinnacle hip replacement system from DePuy has also led to several lawsuits but the trials are not due until September of 2014.
Testimonies from experts revealed that the device will have high failure rates were shared in the court proceedings. Patients felt that they were not informed of all the possible dangers of the device.
The United Kingdom had created their own national joint registry in 2002 and now the United States of America aims to do the same, according to leading newspapers. Most men and women who are past the age of 50 are often at risk of joint problems. By building a national joint registry of its own, the US may be able to help its citizens and nearby North American nations gather reliable information faster and better, medical industry observers say. However the registry is yet to be fully established. The medical device tax that will fund ObamaCare may be starting on the first of January next year, making manufacturers pay more for their sales.
There are already plans on bringing about the structure and all the details that are needed to be fixed have been discussed. But there seems to be some qualms on getting it done. David G. Lewallen, chairman of the American Joint Replacement Registry (AJRR) board of directors, announced in last year’s annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) that this undertaking will be collaborated by several duly established groups. The AJRR used to be an organization supported by the academy but now it will be a joint project that would entail elaborate cooperation with different organizations.
For it to be recognized as a true national registry by the international registry group, it needs to have more than 90 percent of the hospitals in the country to report their joint replacement surgeries. Data collection remains the main focus of the registry and it may aid in research and development of better hip devices and procedure to ensure the safety of patients. Manufacturers may also benefit from the data that may be gathered by the registry. The Food and Drug Administration (FDA) may also find the information helpful as a means of monitoring the devices that they have already approved.
As problems arising from metal-on-metal hip implants continue to attract public attention, the FDA may be able to use the data from the AJRR to evaluate the devices, whether they are to be recalled or not. DePuy ASR is one of the brands that were recalled but there are some people who still have these devices within them. Failure of these devices may not happen to all patients. Several devices have already been taken out from the market because of metal toxicity found among patients. There are even several men and women who are in various stages of filing legal actions against the makers of their prostheses.